PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'INSERM CIC1402, University Hospital of Poitiers, University of Poitiers, 86021, Poitiers Cedex, France; Biology-Pharmacy-Public Health Department, University Hospital of Poitiers, 2 Rue de La Milétrie, 86021, Poitiers Cedex, France. Electronic address: Nicolas.venisse@chu-poitiers.fr.\', \'AP-HP, Bichat Claude Bernard Hospital, Pharmacology-Toxicology Department and IAME, INSERM, UMRS1137, Université de Paris, 75018, Paris, 7, France.\', \'Laboratoire de Pharmaco-Toxicologie, Service de Pharmacologie Médicale, CHU De Bordeaux, INSERM U1219, F-33076, Bordeaux Cedex, France.\', \'Hospices Civils de Lyon, GHS-Centre de Biologie Sud, Pierre Bénite, Lyon, France.\', \'Pharmacologie et Toxicologie Médicales, CHU et Faculté de Médecine de Nice, Université Côte D\'Azur, Nice, France.\', \'Service de Pharmacologie Clinique et Pharmacovigilance, APHM, Institut de Neurosciences des Systèmes, Inserm UMR 1106, Université D\'Aix-Marseille, 13005, Marseille, France.\', \'Aix-Marseille Univ, APHM, Unité des Virus Emergents (UVE) IRD 190, INSERM 1207, Laboratoire de Pharmacocinétique et Toxicologie, Hôpital La Timone, 13005, Marseille, France. Electronic address: Caroline.SOLAS@ap-hm.fr.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0166-3542(20)30280-110.1016/j.antiviral.2020.104866
?:doi
?:hasPublicationType
?:journal
  • Antiviral research
is ?:pmid of
?:pmid
?:pmid
  • 32659293
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.925
?:rankingScore_hIndex
  • 105
?:title
  • Concerns about pharmacokinetic (PK) and pharmacokinetic-pharmacodynamic (PK-PD) studies in the new therapeutic area of COVID-19 infection.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all